ATANIS has been incorporated by the four co-founders Mrs. Noemi Zbären (M. Sc. University of Bern), Prof. em. Dr. med. Jean-Pierre Kinet (Harvard Medical School), Prof. Dr. phil. nat. Thomas Kaufmann (University of Bern) and Prof. Dr. phil. nat. Alexander Eggel (University of Bern). All founders have previously published their work in peer-reviewed high-impact journals and bring >70 years of combined experience in basic and clinical allergy research, cell and molecular biology and diagnostic assay development to the company.
The primary goal of ATANIS is to revolutionize allergy diagnosis by improving patinet safety and diagnostic accuracy
